Cogent Biosciences Q4 EPS $(0.63) Down From $(0.56) YoY
Portfolio Pulse from Happy Mohamed
Cogent Biosciences (NASDAQ:COGT) reported a Q4 EPS loss of $(0.63), marking a 12.5% increase in losses compared to $(0.56) per share from the same period last year.
February 26, 2024 | 1:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cogent Biosciences reported a Q4 EPS loss of $(0.63), a 12.5% increase in losses from the previous year.
The reported increase in losses for Cogent Biosciences is likely to negatively impact investor sentiment in the short term, as it indicates a deterioration in the company's financial performance compared to the same period last year.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100